Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The comparison of the efficacy of ezetimibe and fenofibrate versus atorvastatin alone in the lowering of LDL [low density lipoprotein] cholesterol

Next Previous
Search
Trial Profile

The comparison of the efficacy of ezetimibe and fenofibrate versus atorvastatin alone in the lowering of LDL [low density lipoprotein] cholesterol

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ezetimibe (Primary) ; Fenofibrate (Primary) ; Atorvastatin
  • Indications Dyslipidaemias
  • Focus Therapeutic Use

Most Recent Events

  • 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 13 Oct 2009 Actual end date (July 2006) added as reported by ClinicalTrials.gov.
  • 07 Oct 2006 New trial record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top